New Biogen Data: Experimental Alzheimer's Drug At High Dose Slowed Mental Decline
Biogen's new analysis of its Alzheimer's drug supports its claim that the drug can slow mental decline in the early disease stages. |!| Boston
Biogen's new analysis of its Alzheimer's drug supports its claim that the drug can slow mental decline in the early disease stages. |!| Boston